Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02022800 : Prospective Study on Oncologic Cerebral Imagery Contribution by 18F-FDOPA Position Emission Tomography (PET)
PhaseN/A
AgesMin: 18 Years Max: 85 Years
Eligibility
Inclusion Criteria:

Patients with a historically proven high level of glimoa or of cerebral metastases

Patients who have their files presented in a neurological oncologic CMM in one of the
following situations:

- Diagnosis doubt between radionecrosis and tumor progression

- Evaluation at the end of the radio and chemotherapy period

- Evaluation under anti-angiogenic 18 years or older Patients who have been informed
and have signed the consent form indicated in the study Patients with insurance
coverage

Exclusion Criteria:

Patients for whom having an MRI or a PET 18F-FDOPA would be contraindicated in light of
any co-morbidities or allergies that it reveals
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02022800      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740